Dr. Nishant D. Patel, MD

Dr. Patel practices at Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California.

Dr. Patel's NPI, 1720216153, was assigned on June 24, 2009. Dr. Patel graduated from College of Medicine - Tucson in 2008. Dr. Patel holds California license A120483.

Dr. Patel's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD, at 28078 Baxter Road, Murrieta, CA 92563.

Dr. Patel's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California. The medical group on file is United Medical Doctors. Dmand AI also links Dr. Patel to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Patel is board certified in diplomate by the American Board of Urology. Dmand AI has Dr. Patel's licenses on file in 4 states: California, Virginia, Ohio and Michigan.

Dmand AI lists enlarged prostate, testicular dysfunction, urinary endoscopy and UTI among the conditions Dr. Patel treats.

CMS data shows 505 Medicare services from Dr. Patel across 6 procedure codes in 2024, for 222 Medicare patients. Medicare paid $52,378 for them. Every service was in an office.

CMS counts 222 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 60, with 28% women.

In 2024, Dr. Patel wrote 701 Medicare Part D claims for 164 patients. 86% of them were for generic drugs. CMS names the drug for 521 of them, across 17 drugs with 11 or more claims each, at $75,037 in total drug cost. In 2023, CMS named 68 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 139 papers to Dr. Patel, published from 2008 to 2025. 2023 was the busiest year, with 13. The most frequent topics are Postoperative Complications, Kidney Calculi and Tomography, X-Ray Computed. Dr. Patel has published most often in Cureus. Dr. Patel's most frequent co-authors are Nishant D. Patel, MD, Anjan Trikha, MD and Ravi N. Srinivasa, MD.

CMS Open Payments shows 90 general payments to Dr. Patel from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Stryker Corporation paid the most, $3,600.

Dmand AI lists 2 awards for Dr. Patel, most recently 1st Place Endourological Society Essay Contest in 2017.

Dr. Patel graduated from College of Medicine - Tucson in 2008. Dr. Patel is a member of AUA.

Dr. Patel is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.